Subscribe free

Newsletter

HPB & Spleen

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
Ann Surg31 Dec 2023

Portal Hypertension Assessment Crucial for Hepatocellular Carcinoma Resection Decision

Indirect signs of portal hypertension (pht) don't raise complications risk in hepatocellular carcinoma (HCC) patients undergoing liver resection (LR). However, in patients with hepatic venous pressure gradient (HVPG) ≥10 mmHg, LR significantly increases overall morbidity and liver-related complications risk. Transjugular HVPG assessment is crucial for…

Ann Surg Oncol28 Dec 2023

Low Utilization of Surgical Resection for Locally Advanced Pancreatic Cancer

Despite the positive outcomes reported by high-volume international centers, a multicenter retrospective study in the Netherlands found that surgical resection for locally advanced pancreatic cancer (LAPC) following induction chemotherapy is infrequently performed. Out of 142 patients who underwent resection, only 34.5% met the national comprehensive…

Surg Endosc28 Dec 2023

Robotic Ramps Safely Improves Short-Term Outcomes for Pancreatic Cancer Patients

A retrospective cohort study compared robotic and open radical antegrade modular pancreatosplenectomy (ramps) for pancreatic ductal adenocarcinoma (PDAC) and found that robotic ramps had advantages in operative time, estimated blood loss, delayed gastric emptying, and postoperative hospital stay. The rate of severe postoperative complications was…

J Clin Gastroenterol28 Dec 2023

EUS-Fiducial Markers Improve Pancreas Surgery Guidance

Researchers conducted a preliminary controlled trial to evaluate the feasibility of using endoscopic ultrasound-guided fiducial markers (EUS-FMP) to guide pancreas surgery. The study enrolled 20 patients with resectable pancreas masses and found that EUS-FMP was successful and technically straightforward before planned surgery. Intraoperative detection of…

Ann Surg27 Dec 2023

Estimating the Rate of Low-Yield Surgery in Pancreatic Cancer Surveillance

The prevalence meta-analysis aimed to determine the rate of low-yield surgery in pancreatic cancer surveillance. A systematic search of relevant studies was conducted, including 5027 patients from 23 articles. The pooled prevalence of low-yield surgery was found to be 2.1%, with a slightly higher prevalence…